{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/jaundice-in-adults/diagnosis/assessing-a-person-with-jaundice/","result":{"pageContext":{"chapter":{"id":"7838d032-4715-595c-9029-f183e606749b","slug":"assessing-a-person-with-jaundice","fullItemName":"Assessing a person with jaundice","depth":2,"htmlHeader":"<!-- begin field 710273b3-d45f-417e-a5e0-390acf1273c9 --><h2>How should I assess a person with jaundice?</h2><!-- end field 710273b3-d45f-417e-a5e0-390acf1273c9 -->","summary":"","htmlStringContent":"<!-- begin item a684a818-8487-44f0-8b1b-53bee1e1d367 --><!-- begin field f419a8ad-707e-4292-b930-3f5e4890575c --><ul><li><strong>Assessment of a person with jaundice involves:</strong><ul><li>Taking a <a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/diagnosis/assessing-a-person-with-jaundice/#what-should-i-ask-a-person-with-jaundice\">history</a> and <a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/diagnosis/assessing-a-person-with-jaundice/#how-should-i-examine-a-person-with-jaundice\">examining the person</a> to help identify the underlying cause and any <a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/diagnosis/assessing-a-person-with-jaundice/#red-flags\">red flags</a> for a serious underlying condition.</li><li>Consideration of <a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/diagnosis/assessing-a-person-with-jaundice/#what-investigations-should-i-consider-in-a-person-with-jaundice\">investigations</a> such as blood tests and imaging.</li></ul></li></ul><!-- end field f419a8ad-707e-4292-b930-3f5e4890575c --><!-- end item a684a818-8487-44f0-8b1b-53bee1e1d367 -->","topic":{"id":"517d5301-7d5a-50be-aa9f-5b5f2e5a1ac2","topicId":"2f2490fa-8fe7-4e82-937d-16d0c246af28","topicName":"Jaundice in adults","slug":"jaundice-in-adults","lastRevised":"Last revised in November 2020","chapters":[{"id":"a41fa4d5-aaf9-558f-a200-a15d9ae24b73","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"4b100f17-858f-5860-b737-8358b8ad4e40","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b3211749-3c3a-5d89-863c-5c9a8bac1051","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"7086a372-81e6-56a3-ab69-cae90c352870","slug":"changes","fullItemName":"Changes"},{"id":"75696af8-b6b9-5e35-8d4b-bb9797a7e30e","slug":"update","fullItemName":"Update"}]},{"id":"1f3fdaa2-4042-53bd-bfa1-b9b817765712","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"5dc38689-6ca3-5f08-b82e-a0901a0eb94d","slug":"goals","fullItemName":"Goals"},{"id":"fbabc528-91c0-58ad-85e9-34373cbf2649","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"a478864c-049f-5a95-912c-da77a6409724","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"aaa0268c-73ff-5ed6-8f75-90eb116dbf89","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e58dfa37-a954-5f41-bcf3-cd2264253789","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b1891943-d6c0-5f2f-9a9f-f3204be1ac47","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"08826cc0-037c-5bac-b439-8f79488aed70","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"e132a2db-c13f-58ac-9020-f17d9bc809e7","slug":"definition","fullItemName":"Definition"},{"id":"de318bf6-2016-5a90-939b-19f1d22a779c","slug":"pathophysiology","fullItemName":"Pathophysiology"},{"id":"96c3c504-5932-5b65-83dc-1c20c7848e0a","slug":"causes","fullItemName":"Causes"},{"id":"d76d70a4-a469-5749-a699-59521eb1ead1","slug":"prevalence","fullItemName":"Prevalence"},{"id":"f47fa662-051d-5307-ada7-99b2ada242f4","slug":"risk-factors","fullItemName":"Risk factors"}]},{"id":"7cabc727-d00f-55b2-8a6f-4707af4d7157","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"7838d032-4715-595c-9029-f183e606749b","slug":"assessing-a-person-with-jaundice","fullItemName":"Assessing a person with jaundice"}]},{"id":"48e2dd52-27f9-5631-b987-589ad6f71ae3","fullItemName":"Management","slug":"management","subChapters":[{"id":"f08a38f4-c513-5356-8b70-7562aa88ee0c","slug":"management-of-jaundice-in-adults","fullItemName":"Scenario: Management of jaundice in adults"}]},{"id":"57dfb6aa-c306-5c03-afe4-c2bdd0a93684","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"a665f23d-c451-5c74-9056-8fbd50b70927","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"434744ca-a9a5-5aa1-b361-377e83f269ad","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"ada4134b-bf53-5890-bb39-37e20d7c8c07","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"79937cb7-9330-5001-82f6-a0d844ee98d0","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"730388da-4c3c-55cc-93ad-00439e2a8ee7","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"02a6ff74-c849-5cdf-afc5-046d03ab99d1","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"94689803-b200-5797-a77d-6915ede2f3b1","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"7cabc727-d00f-55b2-8a6f-4707af4d7157","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"e9490709-26be-5908-b87d-7fed6cb3b1b6","slug":"what-should-i-ask-a-person-with-jaundice","fullItemName":"What should I ask a person with jaundice?","depth":3,"htmlHeader":"<!-- begin field d4f02888-a856-4aeb-a2a9-f9675e687984 --><h3>What should I ask a person with jaundice?</h3><!-- end field d4f02888-a856-4aeb-a2a9-f9675e687984 -->","summary":null,"htmlStringContent":"<!-- begin item a27cfb73-5dd4-4e42-bf66-0f6ac03dc00a --><!-- begin field fad6f935-2e70-415d-b4bf-fc9c555f0854 --><ul><li><strong>Take a history including:</strong><ul><li>Duration and previous episodes of jaundice.</li><li>Colour of urine and stools, including any evidence of tarry/bloody stools suggesting melaena.</li><li>Pain including the site, severity, and radiation.</li><li>Itching (pruritus).</li><li>Systemic features such as anorexia, weight loss, fever, rigors, arthralgia, myalgia, rash, fatigue, nausea, and vomiting. Be alert for the presence of any <a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/diagnosis/assessing-a-person-with-jaundice/#red-flags\">red flags</a> that suggest a serious underlying condition such as malignancy. </li><li>Alcohol intake in units — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/alcohol-problem-drinking/\">Alcohol - problem drinking</a> for further information.</li><li>Travel abroad to areas endemic for viral hepatitis and parasites (such as <em>Clonorchis</em>) that can cause jaundice.</li><li>Other risk factors for viral hepatitis — intravenous drug use, tattoos, body piercings, blood transfusion, multiple sexual partners, sex between men or with sex workers.</li><li>Past medical history of biliary surgery, gallstones, hepatitis, autoimmune liver disease, thyroid disease, or non-alcoholic fatty liver disease.</li><li>Co-morbidities such as inflammatory bowel disease (which can increase the risk of primary sclerosing cholangitis), obesity, diabetes, and metabolic syndrome (associated with an increased risk of non-alcoholic fatty liver disease).</li><li>Drugs — prescribed and over-the-counter, including herbal medications and dietary supplements. Always ask about potential paracetamol overdose.</li><li>Occupation — exposure to viral hepatitis, HIV, or hepatotoxic chemicals.</li><li>Family history of inherited anaemias or haemoglobinopathies.</li><li>Possibility of pregnancy — jaundice associated with pregnancy is an obstetric emergency. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/itch-in-pregnancy/\">Itch in pregnancy</a> for further information.</li></ul></li></ul><!-- end field fad6f935-2e70-415d-b4bf-fc9c555f0854 --><!-- end item a27cfb73-5dd4-4e42-bf66-0f6ac03dc00a -->","subChapters":[]},{"id":"196222ea-c1ae-5340-8047-48eadadcf99b","slug":"how-should-i-examine-a-person-with-jaundice","fullItemName":"How should I examine a person with jaundice?","depth":3,"htmlHeader":"<!-- begin field bbebca4d-0991-4de0-8747-5a484cde2344 --><h3>How should I examine a person with jaundice?</h3><!-- end field bbebca4d-0991-4de0-8747-5a484cde2344 -->","summary":null,"htmlStringContent":"<!-- begin item 9089cb44-fd15-4ecb-a254-7d294123b794 --><!-- begin field 6db84545-a6f2-41d8-9e96-c64526c973d5 --><ul><li><strong>Carry out an examination looking for:</strong><ul><li>Signs of sepsis — fever, tachycardia, and hypotension.</li><li>Signs of chronic liver disease:<ul><li>Palmar erythema and spider naevi — up to five spider naevi can be normal in women but in men any suggest chronic liver disease.</li><li>Fingernail clubbing — associated with liver cirrhosis.</li><li>Leukonychia (white nails) — due to hypoalbuminaemia.</li><li>Dupuytren’s contractures (contracture of the palmar fascia) — associated with chronic liver disease due to alcohol misuse but can also be familial or due to other causes such as diabetes mellitus. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/dupuytrens-disease/\">Dupuytren's disease</a> for further information.</li><li>Gynaecomastia (breast enlargement in men), with loss of body hair and testicular atrophy — due to reduced oestrogen breakdown.</li></ul></li><li>Signs of liver failure:<ul><li>Altered neuromuscular function such as ataxia, nystagmus, or asterixis (coarse flapping tremor) can occur with hepatic encephalopathy.</li><li>Altered mental state such as drowsiness, confusion, disorientation, or coma.</li><li>Bruising, petechiae, or purpura.</li></ul></li><li>Lymphadenopathy:<ul><li>Enlargement of the left supraclavicular lymph nodes (Troisier’s sign) can be caused by malignancy including metastatic pancreatic and gastric cancer.</li><li>More widespread lymphadenopathy with hepatosplenomegaly can indicate lymphoma.</li></ul></li><li>Masses such as:<ul><li>Hepatomegaly can be due to many causes including chronic parenchymal liver disease such as alcoholic liver disease or viral hepatitis; malignancy such as primary hepatocellular cancer or secondary metastatic cancer; or haematological disease such as lymphoma or myelofibrosis.</li><li>Splenomegaly can be due to haematological disorders such as lymphoma or haemolytic anaemia; portal hypertension; infections such as glandular fever; or rheumatological conditions such as systemic lupus erythematosus.</li><li>Palpable gallbladder (Courvoisier’s sign) — a palpable gallbladder in a jaundiced person is likely to be due to extra-hepatic obstruction such as from pancreatic cancer.</li></ul></li><li>Abdominal tenderness:<ul><li>Localized tenderness in the right upper quadrant below the costal margin on deep inspiration (Murphy’s sign) may indicate acute cholecystitis.</li><li>Widespread abdominal tenderness may indicate pancreatitis or peritonitis.</li></ul></li><li>Visible veins — collateral vessels on the skin of the abdomen, such as around the umbilicus (caput medusae) indicate chronic liver disease.</li><li>Ascites indicate underlying causes such as intra-abdominal malignancy, chronic liver disease, or severe heart failure.</li></ul></li></ul><!-- end field 6db84545-a6f2-41d8-9e96-c64526c973d5 --><!-- end item 9089cb44-fd15-4ecb-a254-7d294123b794 -->","subChapters":[]},{"id":"a58d1ebd-99be-58d5-8f84-1c6bda05ff72","slug":"what-investigations-should-i-consider-in-a-person-with-jaundice","fullItemName":"What investigations should I consider in a person with jaundice?","depth":3,"htmlHeader":"<!-- begin field f47930a0-780b-45d5-b9f5-7eb663cd61cd --><h3>What investigations should I consider in a person with jaundice?</h3><!-- end field f47930a0-780b-45d5-b9f5-7eb663cd61cd -->","summary":null,"htmlStringContent":"<!-- begin item 41547af9-2fcf-4a0a-91db-83a2fbab7202 --><!-- begin field a90c95f6-1ab9-4882-9df3-5835effcce48 --><ul><li><strong>If the person is well and does not need immediate <a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/management/management-of-jaundice-in-adults/#admission\">admission</a>, arrange blood and urine tests. Note — while the results of some of these tests may influence the <a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/management/management-of-jaundice-in-adults/#referral\">referral</a> pathway for a person with jaundice, do not delay referral while waiting for test results.</strong></li><li><strong>Carry out the following tests:</strong><ul><li>A full blood count — to identify haemolysis or infection.</li><li>Urea and electrolytes — to identify associated renal impairment.</li><li>Liver function tests (LFTs) — see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/diagnosis/assessing-a-person-with-jaundice/#liver-function-tests\">liver function tests</a> for further information on interpretation of LFTs.</li><li>Clotting screen — abnormal clotting can occur in both biliary obstruction and parenchymal liver disease.</li><li>Amylase if pancreatitis is suspected.</li><li>Hepatitis A, B, and C if risk factors are present.</li><li>Urine dipstick — if positive for bilirubin this indicates increased levels of conjugated bilirubin in the serum.</li></ul></li><li>Carbohydrate antigen 19-9 (CA19-9) is <em>not</em> recommended as a screening tool for pancreatic cancer.</li><li><strong>Depending on the results of the initial tests, arrange additional investigations as appropriate:</strong><ul><li>If LFTs show an obstructive picture — see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/jaundice-in-adults/management/management-of-jaundice-in-adults/#referral\">Who should I refer?</a>.</li><li>If LFTs show a non-obstructive picture — carry out a full liver screen, if not already arranged. Consider including:<ul><li>Viral hepatitis screen — hepatitis A, B, and C.</li><li>Immunoglobulins — serum globulins increase in chronic hepatitis and cirrhosis. High levels of IgM are characteristic of primary biliary cirrhosis, and high levels of IgG indicate chronic active hepatitis.</li><li>Auto-antibody profile — to detect autoimmune liver disease.</li><li>Ferritin (and transferrin saturation if ferritin is raised) — to screen for hereditary haemochromatosis.</li><li>Alpha-1-antitrypsin — to detect metabolic liver disease.</li><li>Gamma glutamyltransferase. </li><li>Alpha-fetoprotein — increased levels may indicate hepatocellular carcinoma.</li><li>Caeruloplasmin — in people under 40 years of age. To detect metabolic liver disease.</li><li>HBA1c.</li><li>Thyroid function tests.</li></ul></li><li>Consider arranging an abdominal ultrasound scan or CT scan (the latter is usually requested in secondary care).<ul><li>Ultrasound scan can identify gallbladder stones, dilated bile ducts (indicating extra-hepatic obstruction), liver cysts and tumours, and pancreatic masses. Visualization can be impaired by overlying bowel gas and body habitus.</li><li>CT can be particularly helpful to identify small lesions in the liver and/or pancreas.</li></ul></li></ul></li></ul><!-- end field a90c95f6-1ab9-4882-9df3-5835effcce48 --><!-- end item 41547af9-2fcf-4a0a-91db-83a2fbab7202 -->","subChapters":[]},{"id":"1485c1cc-1eb7-5ed4-9755-7fde8276d510","slug":"red-flags","fullItemName":"Red flags","depth":3,"htmlHeader":"<!-- begin field 5303b84e-34c4-4290-a105-8d82c0e38410 --><h3>Red flags in jaundice</h3><!-- end field 5303b84e-34c4-4290-a105-8d82c0e38410 -->","summary":null,"htmlStringContent":"<!-- begin item 12169fe1-51f5-4d4a-b51e-d94cb570828a --><!-- begin field e975d9bd-7b64-4f4b-896f-b06dbd934d59 --><ul><li><strong>Same-day emergency assessment should be arranged for people presenting with jaundice and the following symptoms or signs:</strong><ul><li>Signs associated with hepatic encephalopathy such as:<ul><li>Confusion or alteration in mental state.</li><li>Altered neuromuscular function such as poor co-ordination, ataxia, asterixis, and nystagmus.</li></ul></li><li>Signs associated with severe hepatic dysfunction such as:<ul><li>Bruising, purpura, or petechiae.</li></ul></li><li>Signs of gastrointestinal blood loss such as:<ul><li>Haematemesis or melaena (black or tarry stools).</li></ul></li><li>Signs associated with sepsis such as:<ul><li>Fever, hypotension, and tachycardia.</li></ul></li><li>Signs associated with ascending cholangitis:<ul><li>Fever and right upper quadrant pain (associated with jaundice, known as 'Charcot's triad').</li></ul></li><li>Marked abdominal tenderness or pain.</li><li>Vomiting.</li><li>Suspected paracetamol overdose.</li></ul></li><li><strong>Urgent referral should be made for people presenting with jaundice and weight loss that may indicate:</strong><ul><li>Underlying malignancy — refer using a suspected cancer pathway, for an appointment within 2 weeks.</li><li>Chronic disease (such as alcoholic cirrhosis) — refer to an appropriate specialist, the urgency depending on clinical judgement.</li></ul></li></ul><!-- end field e975d9bd-7b64-4f4b-896f-b06dbd934d59 --><!-- end item 12169fe1-51f5-4d4a-b51e-d94cb570828a -->","subChapters":[]},{"id":"b6cb6079-0e99-5927-87d7-e580ac3d0a39","slug":"liver-function-tests","fullItemName":"Liver function tests","depth":3,"htmlHeader":"<!-- begin field e6569a6a-3e58-4075-884f-0ae39f2cdcfe --><h3>Interpretation of liver function tests</h3><!-- end field e6569a6a-3e58-4075-884f-0ae39f2cdcfe -->","summary":null,"htmlStringContent":"<!-- begin item 0d94da48-5645-4505-bedb-c865fcf68e2d --><!-- begin field f818ff84-ba27-4365-87f0-7bc3528da9ca --><p>The pattern of abnormality on liver function tests (LFTs) varies depending on the underlying disease process.</p><ul><li><strong>Isolated raised bilirubin</strong><ul><li>This is most often due to <a class=\"topic-reference external-reference\" href=\"/topics/gilberts-syndrome/\">Gilbert's syndrome</a>.<ul><li>Repeat LFTs and full blood count when clinically appropriate to ensure there is no evidence of anaemia or haemolysis.</li></ul></li></ul></li><li><strong>Cholestatic picture</strong><ul><li>Raised alkaline phosphatase (ALP) is the predominant feature. Common causes include primary biliary cholangitis, primary sclerosing cholangitis, biliary obstruction (stones, strictures, tumours), liver congestion, and drug-induced liver injury.</li><li>Bony disease such as Paget's disease can also cause raised ALP and complicate interpretation of LFTs.<ul><li>Repeat the LFTs, the urgency depending on clinical judgement, and add gamma-glutamyl transferase to help confirm a liver cause.</li></ul></li></ul></li><li><strong>Hepatitic picture</strong><ul><li>Predominantly raised alanine transaminase (ALT) and aspartate transaminase (AST).</li><li>ALP may also be raised.</li><li>Caused by hepatocellular liver injury secondary to viral hepatitis, non-alcoholic fatty liver disease (NAFLD), alcohol-related liver disease, autoimmune hepatitis, or drug-induced liver injury.</li><li>Acute viral hepatitis can cause ALT to rise to several thousand units per litre (U/L).</li><li>Acute liver injury from drugs (such as paracetamol overdose) or ischaemia can produce ALT levels greater than 10,000 U/L.</li><li>Acute alcoholic hepatitis can cause AST and ALT to rise to several hundred U/L.</li><li>Alcohol-induced hepatocyte damage usually produces a ratio of AST to ALT greater than 1, whereas infection cause ALT to rise more than AST.</li><li>AST and ALT are not usually raised in obstructive jaundice unless complicated by cholangitis.</li></ul></li></ul><ul><li><strong>Mixed picture</strong><ul><li>Occasionally LFTs may indicate both cholestasis and hepatocyte damage, and this is usually due to cholangitis associated with stones in the common bile duct.</li></ul></li><li><strong>Albumin</strong><ul><li>Low serum albumin suggests chronic liver disease.</li></ul></li></ul><!-- end field f818ff84-ba27-4365-87f0-7bc3528da9ca --><!-- end item 0d94da48-5645-4505-bedb-c865fcf68e2d -->","subChapters":[]},{"id":"d2bb3710-e619-52dc-9a93-7597f5ef68c7","slug":"basis-for-recommendation-f73","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field f26cbf29-8a11-4a70-8da5-9f723c22c212 --><h3>Basis for recommendation</h3><!-- end field f26cbf29-8a11-4a70-8da5-9f723c22c212 -->","summary":null,"htmlStringContent":"<!-- begin item f737f779-b9b6-4d47-8ad3-d7d7578696c5 --><!-- begin field 3fae74cd-18c2-40e9-80aa-dd7fb15ec55b --><p>Recommendations on how to assess a person with jaundice are largely based on expert opinion in the British Society of Gastroenterology <em>Guidelines on the management of abnormal liver blood tests</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Newsome, 2018</a>], the BMJ Best Practice guideline <em>Assessment of jaundice</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">BMJ Best Practice, 2019</a>], and the NICE guideline <em>Suspected cancer: recognition and referral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">NICE, 2020</a>]; the regional Shared Care Pathology guidelines<em> Abnormal liver function tests in adults</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Southern Derbyshire Shared Care Pathology, 2014</a>]; the clinical textbook <em>Macleod’s clinical examination</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Douglas, 2013</a>]; and the review articles <em>ABC of diseases of the liver, pancreas and biliary system. Investigation of liver and biliary disease</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Beckingham, 2001</a>], <em>Jaundice in the adult patient</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Roche, 2004</a>], and <em>Diagnosis and management of cholestatic liver disease</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Heathcote, 2007</a>].</p><h4>Pancreatic cancer</h4><ul><li>The recommendation for not using carbohydrate antigen 19-9 (CA19-9) as a screening tool for pancreatic cancer in primary care is largely based on expert opinion in the review articles <em>Recent developments in the diagnosis of pancreatic cancer </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Takhar, 2004</a>] and <em>Pancreatic adenocarcinoma </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Bond-Smith, 2012</a>], and extrapolation from the NICE guideline <em>Suspected cancer: recognition and referral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">NICE, 2020</a>].<ul><li>People suspected of having pancreatic cancer should be referred under the 2-week rule as testing in primary care does not exclude it.</li><li>The NICE guideline did not identify any evidence on the diagnostic accuracy of CT scan, ultrasound, MRI, carcinoembryonic antigen (CEA), Beta hCG, or the tumour markers CA19-9 and CA72-4 for the diagnosis of pancreatic cancer in primary care settings.</li></ul></li></ul><h4>Thyroid function tests</h4><ul><li>The recommendation on including thyroid function tests in additional blood tests for jaundice is based on expert opinion in the review article <em>An unusual case of jaundice</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/jaundice-in-adults/references/\">Owen, 2007</a>] which states that:<ul><li>'Thyroid hormones are important in maintaining normal hepatic function and for metabolism of bilirubin. Thyrotoxicosis may be associated with various abnormalities in liver function and can be a cause of profound cholestasis.'</li><li>In addition, autoimmune thyroid disease is associated with autoimmune hepatitis and primary biliary cirrhosis.</li></ul></li></ul><!-- end field 3fae74cd-18c2-40e9-80aa-dd7fb15ec55b --><!-- end item f737f779-b9b6-4d47-8ad3-d7d7578696c5 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}